Abstract
At present, nanotechnology is developing at exponential rate because of its widespread applications in biomedical field. Traditionally, nanoparticles are fabricated through variety of physical and chemical approaches but because of their limited efficiency in life sciences, biogenic synthesis of nanoparticles has gained much attention. Biogenically fabricated MgONPs possess unique features that enabled their use in therapeutics and environmental biotechnology. Biogenically MgONPs can be fabricated by employing plant extracts (Manihot esculenta, Rhizophora lamarckii, Ocimum sanctum, Rosemary, Aloe vera, Orange, Artemisia abrotanum, Neem, Bauhinia purpurea), bacteria (S. coelicolor, A. johnsonii RTN), fungi (Aspergillus flavus TFR-12, Aspergillus brasiliensis TFR 2, white-button mushroom’s) and algae (S. whigti). These biogenically synthesized MgONPs are being reported as anti-fungal, antioxidant, antibacterial, anti-pyretic, anti-inflammatory and anti-cancer agents. Moreover, their photocatalytic activity is being discovered against certain organic dyes. This review focuses on biogenic synthesis of MgONPs, their applications in therapeutics and as antimicrobial agents as well as future prospects associated with their application in biomedical field.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Austin Journal of Biomedical Engineering
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
